Microsoft word - 2012 msds aureomycin soluble concentrate.doc
Product Name: Aureomycin® Soluble Concentrate Page: 1 of 5 This revision issued: July, 2012 Section 1 - Identification of The Material and Supplier Pfizer Australia Pty Ltd A.B.N. 50 008 422 348 Chemical nature: Trade Name: Aureomycin® Soluble Concentrate Other Names: Chlortetracycline Hydrochloride APVMA Code: 58255 Product Use:
Prevention and treatment of certain diseases of poultry and pigs. See label for details.
Creation Date: July, 2012 This version issued: July, 2012 and is valid for 5 years from this date. Section 2 - Hazards Identification Statement of Hazardous Nature This product is classified as: N, Dangerous to the environment. Not classified as hazardous according to the criteria of SWA.
Not a Dangerous Good according to the Australian Dangerous Goods (ADG) Code.
Risk Phrases: R53. May cause long term adverse effects in the aquatic environment. Safety Phrases: S22, S36, S24/25. Do not breathe dust. Wear suitable protective clothing. Avoid contact with skin and eyes. SUSMP Classification: S4 ADG Classification: None allocated. Not a Dangerous Good under the ADG Code. UN Number: None allocated Emergency Overview Physical Description & colour: Finely divided tan to dark brown powder with granules. Odour: Mild fermented odour. Major Health Hazards: no significant risk factors have been found for this product. This product is an antibiotic. Any person with a history of allergies to this class of substances should avoid all contact with this product as it may cause sensitisation. Potential Health Effects Note: different Hazard Assessment Criteria of SWA and TGA may result in seeming inconsistencies between MSDS and label. Effects described in this MSDS relate to short term emergency situations, such as accidents and spills with the potential for gross overexposure, and to long term industrial and manufacturing exposure. See product label for assessment of Health Effects of exposure during normal on-farm usage. Inhalation: Short term exposure: Long term inhalation of high amounts of any nuisance dust may overload lung clearance mechanism. Available data indicates that this product is not harmful. However product may be mildly irritating, although unlikely to cause anything more than mild transient discomfort. Long Term exposure: No data for health effects associated with long term inhalation. Skin Contact: Short term exposure: Available data indicates that this product is not harmful. It should present no hazards in normal use. In addition product is unlikely to cause any discomfort in normal use. Long Term exposure: No data for health effects associated with long term skin exposure. Poisons Information Centre: 13 1126 from anywhere in Australia, (0800 764 766 in New Zealand) Product Name: Aureomycin® Soluble Concentrate Page: 2 of 5 This revision issued: July, 2012 Eye Contact: Short term exposure: This product may be irritating to eyes, but is unlikely to cause anything more than mild transient discomfort. Long Term exposure: No data for health effects associated with long term eye exposure. Ingestion: Short term exposure: Significant oral exposure is considered to be unlikely. However, this product may be irritating to mucous membranes but is unlikely to cause anything more than transient discomfort. Long Term exposure: No data for health effects associated with long term ingestion. Carcinogen Status: SWA: No significant ingredient is classified as carcinogenic by SWA. NTP: No significant ingredient is classified as carcinogenic by NTP. IARC: No significant ingredient is classified as carcinogenic by IARC. Section 3 - Composition/Information On Ingredients Ingredients TWA (mg/m3) STEL
This is a commercial product whose exact ratio of components may vary slightly. Minor quantities of other non hazardous ingredients are also possible.
The SWA TWA exposure value is the average airborne concentration of a particular substance when calculated over a normal 8 hour working day for a 5 day working week. The STEL (Short Term Exposure Limit) is an exposure value that may be equalled (but should not be exceeded) for no longer than 15 minutes and should not be repeated more than 4 times per day. There should be at least 60 minutes between successive exposures at the STEL. The term "peak "is used when the TWA limit, because of the rapid action of the substance, should never be exceeded, even briefly.
Section 4 - First Aid Measures General Information:
You should call The Poisons Information Centre if you feel that you may have been poisoned, burned or irritated by this product. The number is 13 1126 from anywhere in Australia (0800 764 766 in New Zealand) and is available at all times. Have this MSDS or product label with you when you call.
Inhalation: First aid is not generally required. If in doubt, contact a Poisons Information Centre or a doctor. Skin Contact: Gently brush away excess solids. Irritation is unlikely. However, if irritation does occur, flush with lukewarm, gently flowing water for 5 minutes or until chemical is removed. Eye Contact: Quickly and gently brush particles from eyes. No effects expected. If irritation does occur, flush contaminated eye(s) with lukewarm, gently flowing water for 5 minutes or until the product is removed. Obtain medical advice if irritation becomes painful or lasts more than a few minutes. Take special care if exposed person is wearing contact lenses. Ingestion: If product is swallowed or gets in mouth, do NOT induce vomiting; wash mouth with water and give some water to drink. If symptoms develop, or if in doubt contact a Poisons Information Centre or a doctor. Section 5 - Fire Fighting Measures Fire and Explosion Hazards: There is no risk of an explosion from this product under normal circumstances if it is involved in a fire. Violent steam generation or eruption may occur upon application of direct water stream on hot liquids. This product, if scattered, may form flammable or explosive dust clouds in air. Fire decomposition products from this product may be toxic if inhaled. Take appropriate protective measures. Extinguishing Media: Preferred extinguishing media are carbon dioxide, dry chemical, foam, water fog. Fire Fighting: If a significant quantity of this product is involved in a fire, call the fire brigade. Do not scatter spilled material with high pressure water jets. Flash point: No Upper Flammability Limit: No Lower Flammability Limit: No Autoignition temperature: No Flammability Class: No Section 6 - Accidental Release Measures Accidental release: In the event of a major spill, prevent spillage from entering drains or water courses. As a minimum, wear overalls, goggles and gloves. Suitable materials for protective clothing include rubber, PVC. Eye/face protective equipment should comprise as a minimum, protective glasses and, preferably, goggles. If there is a Poisons Information Centre: 13 1126 from anywhere in Australia, (0800 764 766 in New Zealand) Product Name: Aureomycin® Soluble Concentrate Page: 3 of 5 This revision issued: July, 2012
significant chance that dusts are likely to build up in cleanup area, we recommend that you use a suitable Dust Mask. Use a P1 mask, designed for use against mechanically generated particles eg silica & asbestos. Stop leak if safe to do so, and contain spill. Sweep up and shovel or collect recoverable product into labelled containers for recycling or salvage, and dispose of promptly. Consider vacuuming if appropriate. Recycle containers wherever possible after careful cleaning. Refer to product label for specific instructions. After spills, wash area preventing runoff from entering drains. If a significant quantity of material enters drains, advise emergency services. Full details regarding disposal of used containers, spillage and unused material may be found on the label. If there is any conflict between this MSDS and the label, instructions on the label prevail. Ensure legality of disposal by consulting regulations prior to disposal. Thoroughly launder protective clothing before storage or re-use. Advise laundry of nature of contamination when sending contaminated clothing to laundry.
Section 7 - Handling And Storage Handling: Keep exposure to this product to a minimum, and minimise the quantities kept in work areas. Check Section 8 of this MSDS for details of personal protective measures, and make sure that those measures are followed. The measures detailed below under "Storage" should be followed during handling in order to minimise risks to persons using the product in the workplace. Also, avoid contact or contamination of product with incompatible materials listed in Section 10. Storage: This product is a Scheduled Poison. Observe all relevant regulations regarding sale, transport and storage of this schedule of poison. Store in the closed original container in a dry, cool (below 25°C), well-ventilated area out of direct sunlight. Make sure that the product does not come into contact with substances listed under "Incompatibilities" in Section 10. Check packaging - there may be further storage instructions on the label. Section 8 - Exposure Controls And Personal Protection This MSDS describes personal protective measures relating to long term industrial and manufacturing exposure, and emergency situations, such as accidents and spills. See product label for personal protective measures during normal on farm usage .
The following Australian Standards will provide general advice regarding safety clothing and equipment:
Respiratory equipment: AS/NZS 1715, Protective Gloves: AS 2161, Occupational Protective Clothing: AS/NZS 4501 set 2008, Industrial Eye Protection: AS1336 and AS/NZS 1337, Occupational Protective Footwear: AS/NZS2210. SWA Exposure Limits TWA (mg/m3) STEL
Exposure limits have not been established by SWA for this product.
The ADI for Chlortetracycline (as hydrochloride) is set at 0.003mg/kg/day. The corresponding NOEL is set at 0.03mg/kg/day. ADI means Acceptable Daily Intake and NOEL means No-observable-effect-level. Values taken from Australian ADI List, Sept 2011.
Ventilation: No special ventilation requirements are normally necessary for this product. However make sure that the work environment remains clean and that dusts are minimised. Eye Protection: Eye protection such as protective glasses or goggles is recommended when this product is being used. Skin Protection: The information at hand indicates that this product is not harmful and that normally no special skin protection is necessary. However, we suggest that you routinely avoid contact with all chemical products and that you wear suitable gloves (preferably elbow-length) when skin contact is likely. Protective Material Types: We suggest that protective clothing be made from the following materials: rubber, PVC. Respirator: If there is a significant chance that dusts are likely to build up in the area where this product is being used, we recommend that you use a suitable Dust Mask. Safety deluge showers should, if practical, be provided near to where this product is being used. Section 9 - Physical And Chemical Properties: Physical Description & colour: Finely divided tan to dark brown powder with granules. Odour: Boiling Point: Not Freezing/Melting Point: Volatiles: No Vapour Pressure:
Negligible at normal ambient temperatures.
Vapour Density: No Specific Gravity: No Water Solubility: Soluble. pH: No Poisons Information Centre: 13 1126 from anywhere in Australia, (0800 764 766 in New Zealand) Product Name: Aureomycin® Soluble Concentrate Page: 4 of 5 This revision issued: July, 2012 Volatility:
Negligible at normal ambient temperatures.
Odour Threshold: No Evaporation Rate: No Coeff Oil/water distribution: No Autoignition temp: No Section 10 - Stability And Reactivity Reactivity: This product is unlikely to react or decompose under normal storage conditions. However, if you have any doubts, contact the supplier for advice on shelf life properties. Conditions to Avoid: Store in the closed original container in a dry, cool, well-ventilated area out of direct sunlight. Incompatibilities: water, acids, bases, strong oxidising agents. Fire Decomposition: Carbon dioxide, and if combustion is incomplete, carbon monoxide and smoke. Nitrogen and its compounds, and under some circumstances, oxides of nitrogen. Occasionally hydrogen cyanide gas in reducing atmospheres. Oxides of sulfur (sulfur dioxide is a respiratory hazard) and other sulfur compounds. Most will have a foul odour. Hydrogen chloride gas, other compounds of chlorine. Water. Carbon monoxide poisoning produces headache, weakness, nausea, dizziness, confusion, dimness of vision, disturbance of judgment, and unconsciousness followed by coma and death. Polymerisation: This product will not undergo polymerisation reactions. Section 11 - Toxicological Information Local Effects: Target Organs: There is no data to hand indicating any particular target organs. Classification of Hazardous Ingredients
No ingredient mentioned in the HSIS Database is present in this product at hazardous concentrations.
Section 12 - Ecological Information
This product may cause long term adverse effects to the aquatic environment.
Section 13 - Disposal Considerations Disposal: There are many pieces of legislation covering waste disposal and they differ in each state and territory, so each user must refer to laws operating in their area. In some areas, certain wastes must be tracked. The Hierarchy of Controls seems to be common - the user should investigate: Reduce, Reuse, and Recycle and only if all else fails should disposal be considered. Note that properties of a product may change in use, so that the following suggestions may not always be appropriate. The following may help you in properly addressing this matter for this product. Special help is available for the disposal of Agricultural Chemicals. The product label will give general advice regarding disposal of small quantities, and how to cleanse containers. However, for help with the collection of unwanted rural chemicals, contact ChemClear 1800 008 182 http://www.chemclear.com.au/ and for help with the disposal of empty drums, contact DrumMuster http://www.drummuster.com.au/ where you will find contact details for your area. Section 14 - Transport Information ADG Code: This product is not classified as a Dangerous Good. No special transport conditions are necessary unless required by other regulations. Section 15 - Regulatory Information AICS: This product is compliant with NICNAS regulations. The following ingredient: Chlortetracycline, is mentioned in the SUSMP. Section 16 - Other Information This MSDS contains only safety-related information. For other data see product literature. Acronyms:
Australian Code for the Transport of Dangerous Goods by Road and Rail (7th edition)
Australian Inventory of Chemical Substances
Safe Work Australia, formerly ASCC and NOHSC
Chemical Abstracts Service Registry Number
Poisons Information Centre: 13 1126 from anywhere in Australia, (0800 764 766 in New Zealand) Product Name: Aureomycin® Soluble Concentrate Page: 5 of 5 This revision issued: July, 2012 Hazchem Code
Emergency action code of numbers and letters that provide information to emergency services especially firefighters
International Agency for Research on Cancer
Standard for the Uniform Scheduling of Medicines & Poisons
UN Number United 1800 814 883 Police and Fire Brigade: If ineffective: Dial Poisons Information Centre (13 1126 from anywhere in Australia)
Please read all labels carefully before using product.
This MSDS copyright Kilford & Kilford Pty Ltd, August, 2012.
http://www.kilford.com.au/ Phone (02)9251 4532
Poisons Information Centre: 13 1126 from anywhere in Australia, (0800 764 766 in New Zealand)
Comunicato Stampa Roma, 12 luglio 2010 GIANLUCA SOMA ENTRA NEL COMITATO DI DIREZIONE DEL GRUPPO SOCIÉTÉ GÉNÉRALE Société Générale annuncia la nomina all’interno del Comitato di Direzione di Gianluca Soma , Amministratore Delegato di ALD International, la divisione del Gruppo SG specializzata nel settore del noleggio a lungo termine e della gestione di flotte auto az
Wissenschaftliche Publikationen in medizinischen Fachjournalen Ernst E, Weihmayr T, Matrai A, Resch KL. Changes in blood rheology of grossly obese individuals during a very low calorie diet. Int J Obes 1989;(Suppl2):167-8. Resch KL, Ernst E, Matrai A, Paulsen HF. Blutfließeigenschaften beeinflussen die Prognose nach Schlaganfall. Perfusion 1990;3:99-110. Resch KL, Ernst E, Matrai A, Schmid